Mt KARI-IN-5
Mt KARI-IN-5 (compound 6c) is a potent Mycobacterium tuberculosis ketol-acid reductoisomerase (Mtb KARI) inhibitor with a Ki value of 4.72 μM. Mt KARI-IN-5 has inhibitory activity against Mtb H37Rv (MIC = 1.56 μM) and low cytotoxicity (HEK IC50 > 64 μg/mL) [1]
Product Specifications
CAS Number
2413974-69-1
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mt-kari-in-5.html
Solubility
10 mM in DMSO
Smiles
CC(C1=CC=C(C=C1)S(=O)(NC2=NN=C(S2)C3=CC=C(S3)[N+]([O-])=O)=O)=O
Molecular Formula
C14H10N4O5S3
Molecular Weight
410.45
References & Citations
[1]Krishna VS, et al. Design and development of ((4-methoxyphenyl) carbamoyl) (5- (5-nitrothiophen-2-yl) -1,3,4-thiadiazol-2-yl) amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. Eur J Med Chem. 2020;193:112178.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
N0800-ML405 100 µL
NEK1, CT (Never in Mitosis A-related Kinase 1, NimA-related Protein Kinase 1, KIAA1901, MGC138800, NY-REN-55, Renal Carcinoma Antigen NY-REN-55, Serine/threonine Protein Kinase Nek1) (MaxLight 405) discontinued
Sign In for Pricing
View Details